Join
Live feed
·
PRReleasevia Quantisnow
Medicus Pharma Ltd. logo

Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

ByQuantisnow·Wall Street's wire, on your screen.
MDCX· Medicus Pharma Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDCX (Medicus Pharma Ltd.) and more on Quantisnow.